FI113547B - Geloniinia koodaava synteettinen geeni ja välineitä ja menetelmiä geenin ja proteiinin tuottamiseksi - Google Patents
Geloniinia koodaava synteettinen geeni ja välineitä ja menetelmiä geenin ja proteiinin tuottamiseksi Download PDFInfo
- Publication number
- FI113547B FI113547B FI941048A FI941048A FI113547B FI 113547 B FI113547 B FI 113547B FI 941048 A FI941048 A FI 941048A FI 941048 A FI941048 A FI 941048A FI 113547 B FI113547 B FI 113547B
- Authority
- FI
- Finland
- Prior art keywords
- gene
- dna
- expression
- sequence
- synthetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75594991A | 1991-09-06 | 1991-09-06 | |
| US75594991 | 1991-09-06 | ||
| US9207066 | 1992-08-21 | ||
| PCT/US1992/007066 WO1993005168A1 (en) | 1991-09-06 | 1992-08-21 | Dna sequences encoding gelonin polypeptide |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI941048A0 FI941048A0 (fi) | 1994-03-04 |
| FI941048A FI941048A (fi) | 1994-03-04 |
| FI113547B true FI113547B (fi) | 2004-05-14 |
Family
ID=25041367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI941048A FI113547B (fi) | 1991-09-06 | 1994-03-04 | Geloniinia koodaava synteettinen geeni ja välineitä ja menetelmiä geenin ja proteiinin tuottamiseksi |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5624827A (de) |
| EP (1) | EP0602144B1 (de) |
| JP (1) | JPH06510431A (de) |
| KR (1) | KR100270195B1 (de) |
| CN (1) | CN1047402C (de) |
| AT (1) | ATE173023T1 (de) |
| AU (1) | AU679427B2 (de) |
| CA (1) | CA2115049C (de) |
| DE (1) | DE69227519T2 (de) |
| DK (1) | DK0602144T3 (de) |
| ES (1) | ES2123008T3 (de) |
| FI (1) | FI113547B (de) |
| IL (1) | IL103057A (de) |
| NO (1) | NO317659B1 (de) |
| NZ (1) | NZ244220A (de) |
| RU (1) | RU2142015C1 (de) |
| WO (1) | WO1993005168A1 (de) |
| ZA (1) | ZA926705B (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5317009A (en) * | 1991-08-26 | 1994-05-31 | New York University | Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof |
| US6146850A (en) * | 1991-11-04 | 2000-11-14 | Xoma Corporation | Proteins encoding gelonin sequences |
| US5621083A (en) * | 1991-11-04 | 1997-04-15 | Xoma Corporation | Immunotoxins comprising ribosome-inactivating proteins |
| US5837491A (en) * | 1991-11-04 | 1998-11-17 | Xoma Corporation | Polynucleotides encoding gelonin sequences |
| WO1994026910A1 (en) * | 1993-05-12 | 1994-11-24 | Xoma Corporation | Immunotoxins comprising gelonin and an antibody |
| US5869619A (en) * | 1991-12-13 | 1999-02-09 | Xoma Corporation | Modified antibody variable domains |
| EP1291360A1 (de) * | 1991-12-13 | 2003-03-12 | Xoma Corporation | Verfahren und Materialien zur Herstellung von modifizierten Antikörper Variablen Domänen und deren therapeutischen Verwendung |
| US20030166169A1 (en) * | 1998-01-16 | 2003-09-04 | Padgett Hal S. | Method for constructing viral nucleic acids in a cell-free manner |
| ZA200305980B (en) | 2001-02-12 | 2007-01-31 | Res Dev Foundation | Modified proteins, designer toxins, and methods of making thereof |
| CN1555268B (zh) * | 2001-07-17 | 2013-04-03 | 研究发展基金会 | 含促调亡蛋白质的治疗剂 |
| CA2488858A1 (en) * | 2002-06-12 | 2003-12-24 | Research Development Foundation | Immunotoxin as a therapeutic agent and uses thereof |
| EP2298806A1 (de) | 2002-10-16 | 2011-03-23 | Purdue Pharma L.P. | Antikörper, die an zellassoziiertes CA 125/0722P binden, und Verfahren zu deren Anwendung |
| US20060171919A1 (en) * | 2005-02-01 | 2006-08-03 | Research Development Foundation | Targeted polypeptides |
| KR101224828B1 (ko) * | 2009-05-14 | 2013-01-22 | (주)바이오니아 | ｓｉＲＮＡ 접합체 및 그 제조방법 |
| US8759036B2 (en) | 2011-03-21 | 2014-06-24 | Affymetrix, Inc. | Methods for synthesizing pools of probes |
| WO2014153188A2 (en) | 2013-03-14 | 2014-09-25 | Life Technologies Corporation | High efficiency, small volume nucleic acid synthesis |
| LT2768607T (lt) | 2011-09-26 | 2021-12-27 | Thermo Fisher Scientific Geneart Gmbh | Daugiašulininė plokštelė didelio efektyvumo, mažo tūrio nukleorūgščių sintezei atlikti |
| US9096840B2 (en) | 2012-10-04 | 2015-08-04 | Research Development Foundation | Serine protease molecules and therapies |
| CN107532129B (zh) | 2014-12-09 | 2022-09-13 | 生命技术公司 | 高效小体积核酸合成 |
| EP3359669B1 (de) | 2015-10-06 | 2020-05-13 | Pierce Biotechnology, Inc. | Vorrichtungen und verfahren zur herstellung von proteinen |
| WO2020001783A1 (en) | 2018-06-29 | 2020-01-02 | Thermo Fisher Scientific Geneart Gmbh | High throughput assembly of nucleic acid molecules |
| GB201905303D0 (en) | 2019-04-15 | 2019-05-29 | Thermo Fisher Scient Geneart Gmbh | Multiplex assembly of nucleic acid molecules |
| WO2021178809A1 (en) | 2020-03-06 | 2021-09-10 | Life Technologies Corporation | High sequence fidelity nucleic acid synthesis and assembly |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4888415A (en) * | 1985-03-04 | 1989-12-19 | Dana-Farber Cancer Institute, Inc. | Gelonin immunotoxin |
| US5024947A (en) * | 1987-07-24 | 1991-06-18 | Cetus Corporation | Serum free media for the growth on insect cells and expression of products thereby |
| US5290914A (en) * | 1988-04-28 | 1994-03-01 | Mycogen Corporation | Hybrid diphtheria-B.t. pesticidal toxins |
| IE912716A1 (en) * | 1990-08-14 | 1992-02-26 | Res Dev Foundation | Protein Structure of the Plant Toxin Gelonin |
-
1992
- 1992-08-21 WO PCT/US1992/007066 patent/WO1993005168A1/en active IP Right Grant
- 1992-08-21 RU RU94034733A patent/RU2142015C1/ru not_active IP Right Cessation
- 1992-08-21 KR KR1019940700732A patent/KR100270195B1/ko not_active IP Right Cessation
- 1992-08-21 DK DK92919264T patent/DK0602144T3/da active
- 1992-08-21 DE DE69227519T patent/DE69227519T2/de not_active Expired - Lifetime
- 1992-08-21 ES ES92919264T patent/ES2123008T3/es not_active Expired - Lifetime
- 1992-08-21 JP JP5505226A patent/JPH06510431A/ja active Pending
- 1992-08-21 EP EP92919264A patent/EP0602144B1/de not_active Expired - Lifetime
- 1992-08-21 CA CA002115049A patent/CA2115049C/en not_active Expired - Fee Related
- 1992-08-21 AT AT92919264T patent/ATE173023T1/de not_active IP Right Cessation
- 1992-08-21 AU AU25476/92A patent/AU679427B2/en not_active Ceased
- 1992-09-04 CN CN92110105A patent/CN1047402C/zh not_active Expired - Fee Related
- 1992-09-04 NZ NZ244220A patent/NZ244220A/en not_active IP Right Cessation
- 1992-09-04 ZA ZA926705A patent/ZA926705B/xx unknown
- 1992-09-04 IL IL10305792A patent/IL103057A/en not_active IP Right Cessation
-
1994
- 1994-03-03 NO NO19940736A patent/NO317659B1/no not_active IP Right Cessation
- 1994-03-04 FI FI941048A patent/FI113547B/fi active
- 1994-10-21 US US08/327,440 patent/US5624827A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0602144A1 (de) | 1994-06-22 |
| DE69227519T2 (de) | 1999-06-02 |
| ZA926705B (en) | 1993-04-28 |
| NO317659B1 (no) | 2004-11-29 |
| WO1993005168A1 (en) | 1993-03-18 |
| NO940736D0 (no) | 1994-03-03 |
| EP0602144A4 (de) | 1995-03-15 |
| CA2115049C (en) | 2003-10-21 |
| AU679427B2 (en) | 1997-07-03 |
| IL103057A (en) | 1999-09-22 |
| RU94034733A (ru) | 1996-06-10 |
| AU2547692A (en) | 1993-04-05 |
| NZ244220A (en) | 1994-12-22 |
| FI941048A0 (fi) | 1994-03-04 |
| US5624827A (en) | 1997-04-29 |
| CN1047402C (zh) | 1999-12-15 |
| EP0602144B1 (de) | 1998-11-04 |
| KR100270195B1 (ko) | 2001-03-02 |
| CA2115049A1 (en) | 1993-03-18 |
| DE69227519D1 (de) | 1998-12-10 |
| FI941048A (fi) | 1994-03-04 |
| CN1070227A (zh) | 1993-03-24 |
| DK0602144T3 (da) | 1999-07-19 |
| RU2142015C1 (ru) | 1999-11-27 |
| JPH06510431A (ja) | 1994-11-24 |
| IL103057A0 (en) | 1993-02-21 |
| NO940736L (no) | 1994-03-03 |
| ATE173023T1 (de) | 1998-11-15 |
| ES2123008T3 (es) | 1999-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI113547B (fi) | Geloniinia koodaava synteettinen geeni ja välineitä ja menetelmiä geenin ja proteiinin tuottamiseksi | |
| JP2781459B2 (ja) | ヒト血清アルブミンのｎ―末端フラグメント含有融合蛋白質 | |
| JPS61501449A (ja) | 毒素複合体 | |
| EP0238101A1 (de) | Mikrobiologische Expression von Interleukin-II | |
| JPH0789934B2 (ja) | 構造遺伝子の製造および発現 | |
| KR870009020A (ko) | 하이브리드 인터페론 및 그의 제조방법 | |
| EP0150572A1 (de) | Mikrobielle Expression des Transformationswachstumsfaktors Typ I, analoge Polypeptide hiervon und EGF/TGF-Hybridpolypeptide | |
| CA1340091C (en) | Enhanced protein production in bacteria by employing novel ribosome binding site | |
| JPS584799A (ja) | 成熟ソ−マチンの遺伝暗号を有するｄｎａ配列 | |
| CA2076320C (en) | Process for producing peptide | |
| JP2612264B2 (ja) | Ｄｎａ配列体 | |
| JPS62153300A (ja) | ヒト免疫グロブリンＧＦｃ領域蛋白質およびその製造方法 | |
| JPH0848700A (ja) | 組換えリシン毒素フラグメント | |
| WO1997049726A1 (en) | Recombinant ribosomal inhibitor protein (rip) and use as immunoconjugate | |
| US5017486A (en) | Cloning of DNA encoding antibacterial polypeptide precursor | |
| JP2545377B2 (ja) | Ｄｎａ配列体 | |
| JPS62232387A (ja) | 組換リシントキシン | |
| EP0504919B1 (de) | Antiviren-Protein aus Mirabilis jalapa | |
| JPH0928380A (ja) | ニトリラーゼ遺伝子発現に関わる調節因子およびその遺伝子 | |
| JPH06306100A (ja) | Ｖｉｐアナログ調製用融合蛋白、ｖｉｐアナログの製法並びにそのための遺伝子組換えプラスミド及び形質転換微生物 | |
| JPS60502136A (ja) | 微生物によるインタ−ル−キン２の形質発現 | |
| KR910000459B1 (ko) | 인간성장호르몬 발현 벡터 pYLBC-A/G-HGH | |
| JPS60188070A (ja) | シグナルペプチドをコードするｄｎａ | |
| IE922506A1 (en) | Nucleotide sequences coding for ribosome inactivating¹proteins | |
| JPS59501095A (ja) | カルシトニンおよびその類似体のための遺伝子の製造と発現 |